Showing results (271-280 of 298) with videos related to
Sort By:
Pageof 30
Nature|October 31, 1996
Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor geneH W Matthes, R Maldonado, F Simonin, et al.Antimicrobial Agents and Chemotherapy|October 9, 2013
In vitro phenotypic characterization of hepatitis C virus NS3 protease variants observed in clinical studies of telaprevirMin Jiang, Nagraj Mani, Chao Lin, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 1, 2021
Mu opioid receptors on hippocampal GABAergic interneurons are critical for the antidepressant effects of tianeptineJaena Han, Valentine Andreu, Cory Langreck, et al.Antimicrobial Agents and Chemotherapy|July 2, 2014
Genotypic and phenotypic analyses of hepatitis C virus variants observed in clinical studies of VX-222, a nonnucleoside NS5B polymerase inhibitorMin Jiang, Eileen Z Zhang, Andrzej Ardzinski, et al.Brain Structure & Function|March 14, 2014
A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networksEric Erbs, Lauren Faget, Gregory Scherrer, et al.Brain Structure & Function|November 8, 2017
Mapping GPR88-Venus illuminates a novel role for GPR88 in sensory processingAliza T Ehrlich, Meriem Semache, Julie Bailly, et al.Addiction Biology|June 19, 2025
The GPR88 Agonist RTI-122 Reduces Alcohol-Related Motivation and ConsumptionDennis F Lovelock, Wen Liu, Sami Ben Hamida, et al.Science (New York, N.Y.)|October 12, 2019
Control of aversion by glycine-gated GluN1/GluN3A NMDA receptors in the adult medial habenulaY Otsu, E Darcq, K Pietrajtis, et al.JAMA|February 17, 2005
Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAARTRichard E Nettles, Tara L Kieffer, Patty Kwon, et al.Neuropeptides|October 16, 2012
The endogenous opioid dynorphin is required for normal bone homeostasis in micePaul A Baldock, Frank Driessler, Shu Lin, et al.Pageof 30